Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225654 · ClinicalTrials.gov registry record · NA
The ELUTES Clinical Trial
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT00225654 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 192 participants.
The verdict
NCT00225654, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
ELUTES is a European multicenter, randomized, controlled, triple-blinded study designed to evaluate the ability of the Paclitaxel Eluting V-Flex Plus coronary stent to reduce restenosis in the coronary artery.
Interventions
- DEVICE coronary stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2000-01 |
| Est. Completion | 2001-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00225654
The ClinicalTrials.gov registry entry for NCT00225654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which coronary stent is the first listed.
NCT00225654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00225654 about?
NCT00225654 is a clinical study titled "The ELUTES Clinical Trial". ELUTES is a European multicenter, randomized, controlled, triple-blinded study designed to evaluate the ability of the Paclitaxel Eluting V-Flex Plus coronary stent to reduce restenosis in the coronary artery.
What is the current status of trial NCT00225654?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2000-01. Estimated completion is 2001-11.
What interventions are being tested in trial NCT00225654?
The interventions under investigation include: coronary stent (DEVICE).
Who is sponsoring clinical trial NCT00225654?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.